Exact Sciences (NASDAQ:EXAS) announces its next round of earnings this Tuesday, February 16. Here is Benzinga's look at Exact Sciences's Q4 earnings report.
Earnings And Revenue
Exact Sciences EPS loss is expected to be around $0.22, according to sell-side analysts. Sales will likely be near $446.22 million. In the same quarter last year, Exact Sciences reported EPS of $0.37 on revenue of $295.57 million.
What Are Analyst Estimates And Earnings Surprises, And Why Do They Matter?
Analysts who cover this company will publish forward-looking estimates of its revenue and EPS each quarter. Averaging together every EPS and revenue prediction that each analyst makes about a company in a quarter yields the "consensus estimates." A company posting earnings or revenue above or below the consensus estimate is known as an "earnings surprise" and may move the stock by a considerable margin.
If the company were to match the consensus estimate when it reports Tuesday, EPS would be up 40.54%. Revenue would be up 50.97% from the year-ago period. Here is how the company's reported EPS has stacked up against analyst estimates in the past:
Quarter | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2020 |
|---|---|---|---|---|
EPS Estimate | -0.52 | -0.63 | -0.61 | -0.34 |
EPS Actual | -0.07 | -0.58 | -0.66 | -0.37 |
Revenue Estimate | 337.37 M | 228.42 M | 350.39 M | 281.78 M |
Revenue Actual https://finance.yahoo.com/news/preview-exact-sciencess-earnings-153416759.html | 408.36 M | 268.87 M | 347.82 M | 295.57 M |
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.